 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.13
- Protein kinase C.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + a protein = ADP + a phosphoprotein
|
 |
 |
 |
 |
 |
ATP
|
+
|
protein
|
=
|
ADP
|
+
|
phosphoprotein
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
protein amino acid phosphorylation
|
1 term
|
 |
|
Biochemical function
|
protein kinase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
279:50401-50409
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Catalytic domain crystal structure of protein kinase C-theta (PKCtheta).
|
|
Z.B.Xu,
D.Chaudhary,
S.Olland,
S.Wolfrom,
R.Czerwinski,
K.Malakian,
L.Lin,
M.L.Stahl,
D.Joseph-McCarthy,
C.Benander,
L.Fitz,
R.Greco,
W.S.Somers,
L.Mosyak.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A member of the novel protein kinase C (PKC) subfamily, PKC, is an essential
component of the T cell synapse and is required for optimal T cell activation
and interleukin-2 production. Selective involvement of PKC in TCR signaling
makes this enzyme an attractive therapeutic target in T cell-mediated disease
processes. In this report we describe the crystal structure of the catalytic
domain of PKC at 2.0-A resolution. Human recombinant PKC kinase domain was
expressed in bacteria as catalytically active phosphorylated enzyme and
co-crystallized with its subnanomolar, ATP site inhibitor staurosporine. The
structure follows the classic bilobal kinase fold and shows the enzyme in its
active conformation and phosphorylated state. Inhibitory interactions between
conserved features of staurosporine and the ATP-binding cleft are accompanied by
closing of the glycine-rich loop, which also maintains an inhibitory arrangement
by blocking the phosphate recognition subsite. The two major phosphorylation
sites, Thr-538 in the activation loop and Ser-695 in the hydrophobic motif, are
both occupied in the structure, playing key roles in stabilizing active
conformation of the enzyme and indicative of PKC autocatalytic phosphorylation
and activation during bacterial expression. The PKC-staurosporine complex
represents the first kinase domain crystal structure of any PKC isotypes to be
determined and as such should provide valuable insight into PKC specificity and
into rational drug design strategies for PKC selective leads.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIG. 2. Overall structure of the PKC -staurosporine complex
and comparison with the structure of the PKA-staurosporine-PKI
complex. A, ribbon representation of the PKC kinase domain
structure. The N-lobe is cyan and the C-lobe is blue. The
glycine-rich loop, activation loop, and HM segment are
highlighted in red. Staurosporine and phosphorylated residues
are shown in stick representation. B, superposition of PKC -staurosporine (color
coding is the same as described for A) and PKA-staurosporine-PKI
structures (yellow ribbons and sticks; PDB code: 1STC [PDB]
(20)). Phosphorylated sites in PKA are also shown. Structures
were aligned using the central helices from the C-lobe. Both
staurosporine-bound kinases display intermediate lobe structures
with conformational differences in the glycine-rich loop.
|
 |
Figure 4.
FIG. 4. The activation loop and helix C. The ribbon drawing
of PKC (N-lobe in cyan, C-lobe
in blue) highlights key structural motifs at the catalytic
cleft. Selected residues are in stick representation. Dashed red
lines depict specific hydrogen-bonding interactions of the
essential Thr-538(P) phosphate with cationic pocket (Arg-503,
Lys-527) and of the C helix with catalytic
Lys-409 and activation loop (Glu-528).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
50401-50409)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.F.Djung,
R.J.Mears,
C.A.Montalbetti,
T.S.Coulter,
A.Golebiowski,
A.N.Carr,
O.Barker,
K.D.Greis,
S.Zhou,
E.Dolan,
and
G.F.Davis
(2011).
The synthesis and evaluation of indolylureas as PKCα inhibitors.
|
| |
Bioorg Med Chem, 19,
2742-2750.
|
 |
|
|
|
|
 |
T.A.Leonard,
B.Różycki,
L.F.Saidi,
G.Hummer,
and
J.H.Hurley
(2011).
Crystal structure and allosteric activation of protein kinase C βII.
|
| |
Cell, 144,
55-66.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.C.Newton
(2010).
Protein kinase C: poised to signal.
|
| |
Am J Physiol Endocrinol Metab, 298,
E395-E402.
|
 |
|
|
|
|
 |
C.E.Cassidy,
and
W.N.Setzer
(2010).
Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.
|
| |
J Mol Model, 16,
311-326.
|
 |
|
|
|
|
 |
J.van Ameijde,
A.J.Poot,
L.T.van Wandelen,
A.E.Wammes,
R.Ruijtenbeek,
D.T.Rijkers,
and
R.M.Liskamp
(2010).
Preparation of novel alkylated arginine derivatives suitable for click-cycloaddition chemistry and their incorporation into pseudosubstrate- and bisubstrate-based kinase inhibitors.
|
| |
Org Biomol Chem, 8,
1629-1639.
|
 |
|
|
|
|
 |
T.Takimura,
K.Kamata,
K.Fukasawa,
H.Ohsawa,
H.Komatani,
T.Yoshizumi,
I.Takahashi,
H.Kotani,
and
Y.Iwasawa
(2010).
Structures of the PKC-iota kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533-551 in the C-terminal tail and their roles in ATP binding.
|
| |
Acta Crystallogr D Biol Crystallogr, 66,
577-583.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Filatova,
M.Leyerer,
V.Gorboulev,
C.Chintalapati,
Y.Reinders,
T.D.Müller,
A.Srinivasan,
S.Hübner,
and
H.Koepsell
(2009).
Novel shuttling domain in a regulator (RSC1A1) of transporter SGLT1 steers cell cycle-dependent nuclear location.
|
| |
Traffic, 10,
1599-1618.
|
 |
|
|
|
|
 |
A.J.Cameron,
C.Escribano,
A.T.Saurin,
B.Kostelecky,
and
P.J.Parker
(2009).
PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity.
|
| |
Nat Struct Mol Biol, 16,
624-630.
|
 |
|
|
|
|
 |
A.J.Poot,
J.van Ameijde,
M.Slijper,
A.van den Berg,
R.Hilhorst,
R.Ruijtenbeek,
D.T.Rijkers,
and
R.M.Liskamp
(2009).
Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
|
| |
Chembiochem, 10,
2042-2051.
|
 |
|
|
|
|
 |
B.Nagy,
K.Bhavaraju,
T.Getz,
Y.S.Bynagari,
S.Kim,
and
S.P.Kunapuli
(2009).
Impaired activation of platelets lacking protein kinase C-theta isoform.
|
| |
Blood, 113,
2557-2567.
|
 |
|
|
|
|
 |
C.C.Huang,
K.Yoshino-Koh,
and
J.J.Tesmer
(2009).
A surface of the kinase domain critical for the allosteric activation of G protein-coupled receptor kinases.
|
| |
J Biol Chem, 284,
17206-17215.
|
 |
|
|
|
|
 |
J.H.Daniel
(2009).
A fitness-based interferential genetics approach using hypertoxic/inactive gene alleles as references.
|
| |
Mol Genet Genomics, 281,
437-445.
|
 |
|
|
|
|
 |
J.M.Elkins,
A.Amos,
F.H.Niesen,
A.C.Pike,
O.Fedorov,
and
S.Knapp
(2009).
Structure of dystrophia myotonica protein kinase.
|
| |
Protein Sci, 18,
782-791.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.F.Steinberg
(2008).
Structural basis of protein kinase C isoform function.
|
| |
Physiol Rev, 88,
1341-1378.
|
 |
|
|
|
|
 |
S.Tang,
V.Xiao,
L.Wei,
C.I.Whiteside,
and
L.P.Kotra
(2008).
Protein kinase C isozymes and their selectivity towards ruboxistaurin.
|
| |
Proteins, 72,
447-460.
|
 |
|
|
|
|
 |
Y.Liu,
K.S.Matthews,
and
S.E.Bondos
(2008).
Multiple intrinsically disordered sequences alter DNA binding by the homeodomain of the Drosophila hox protein ultrabithorax.
|
| |
J Biol Chem, 283,
20874-20887.
|
 |
|
|
|
|
 |
H.Al-Ali,
T.J.Ragan,
X.Gao,
and
T.K.Harris
(2007).
Reconstitution of modular PDK1 functions on trans-splicing of the regulatory PH and catalytic kinase domains.
|
| |
Bioconjug Chem, 18,
1294-1302.
|
 |
|
|
|
|
 |
P.C.Whitford,
O.Miyashita,
Y.Levy,
and
J.N.Onuchic
(2007).
Conformational transitions of adenylate kinase: switching by cracking.
|
| |
J Mol Biol, 366,
1661-1671.
|
 |
|
|
|
|
 |
S.Ranganathan,
Y.Wang,
F.G.Kern,
Z.Qu,
and
R.Li
(2007).
Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
|
| |
Proteins, 67,
709-719.
|
 |
|
|
|
|
 |
V.S.Gowri,
K.Anamika,
S.Gore,
and
N.Srinivasan
(2007).
Analysis on sliding helices and strands in protein structural comparisons: a case study with protein kinases.
|
| |
J Biosci, 32,
921-928.
|
 |
|
|
|
|
 |
C.A.O'Brian,
F.Chu,
W.G.Bornmann,
and
D.S.Maxwell
(2006).
Protein kinase Calpha and epsilon small-molecule targeted therapeutics: a new roadmap to two Holy Grails in drug discovery?
|
| |
Expert Rev Anticancer Ther, 6,
175-186.
|
 |
|
|
|
|
 |
C.Sánchez,
C.Méndez,
and
J.A.Salas
(2006).
Indolocarbazole natural products: occurrence, biosynthesis, and biological activity.
|
| |
Nat Prod Rep, 23,
1007-1045.
|
 |
|
|
|
|
 |
M.Engel,
V.Hindie,
L.A.Lopez-Garcia,
A.Stroba,
F.Schaeffer,
I.Adrian,
J.Imig,
L.Idrissova,
W.Nastainczyk,
S.Zeuzem,
P.M.Alzari,
R.W.Hartmann,
A.Piiper,
and
R.M.Biondi
(2006).
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.
|
| |
EMBO J, 25,
5469-5480.
|
 |
|
|
|
|
 |
M.G.Gold,
D.Barford,
and
D.Komander
(2006).
Lining the pockets of kinases and phosphatases.
|
| |
Curr Opin Struct Biol, 16,
693-701.
|
 |
|
|
|
|
 |
M.Tanaka,
S.Sagawa,
J.Hoshi,
F.Shimoma,
K.Yasue,
M.Ubukata,
T.Ikemoto,
Y.Hase,
M.Takahashi,
T.Sasase,
N.Ueda,
M.Matsushita,
and
T.Inaba
(2006).
Synthesis, SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCbeta-selective inhibitors.
|
| |
Bioorg Med Chem, 14,
5781-5794.
|
 |
|
|
|
|
 |
S.Ohashi,
G.Sakashita,
R.Ban,
M.Nagasawa,
H.Matsuzaki,
Y.Murata,
H.Taniguchi,
H.Shima,
K.Furukawa,
and
T.Urano
(2006).
Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies.
|
| |
Oncogene, 25,
7691-7702.
|
 |
|
|
|
|
 |
S.Sánchez-Bautista,
A.Kazaks,
M.Beaulande,
A.Torrecillas,
S.Corbalán-García,
and
J.C.Gómez-Fernández
(2006).
Structural study of the catalytic domain of PKCzeta using infrared spectroscopy and two-dimensional infrared correlation spectroscopy.
|
| |
FEBS J, 273,
3273-3286.
|
 |
|
|
|
|
 |
C.C.Kumar,
and
V.Madison
(2005).
AKT crystal structure and AKT-specific inhibitors.
|
| |
Oncogene, 24,
7493-7501.
|
 |
|
|
|
|
 |
N.Thuille,
I.Heit,
F.Fresser,
N.Krumböck,
B.Bauer,
S.Leuthaeusser,
S.Dammeier,
C.Graham,
T.D.Copeland,
S.Shaw,
and
G.Baier
(2005).
Critical role of novel Thr-219 autophosphorylation for the cellular function of PKCtheta in T lymphocytes.
|
| |
EMBO J, 24,
3869-3880.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|